Form 4: Tecogen Director Angelina Galiteva Granted 25,000 Stock Options

Tecogen Inc. director Angelina Galiteva was granted 25,000 stock options with an exercise price of $8.35, vesting annually over four years.

Summary

• Angelina Galiteva, a Director of Tecogen Inc. (TGEN), was granted 25,000 stock options.
• The options have an exercise price of $8.35 per share.
• The transaction date for the grant was July 24, 2025.
• The options begin vesting on July 24, 2026, at a rate of 25% per year.
• The options have an expiration date of July 25, 2035.
• Following this transaction, Angelina Galiteva beneficially owns 225,000 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The sentiment is positive as it represents a standard compensation grant to a director, aligning their interests with the company's long-term success. It does not indicate any negative operational or financial news.

Positives

• The grant of stock options to a director aligns their interests with those of shareholders, incentivizing long-term company performance.
• The vesting schedule encourages continued service and commitment from the director.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with shareholder value creation, as the options gain value if the stock price increases.
• Employees: No direct impact mentioned, but general positive sentiment from board stability and incentivization could indirectly benefit morale.

Key Dates

Keywords

Tecogen Inc., TGEN, Angelina Galiteva, Stock Options, Director Compensation, SEC Form 4, Insider Transaction, Equity Grant, Beneficial Ownership